Franklin Resources
NKTR icon

Franklin Resources’s Nektar Therapeutics NKTR Stock Holding History

Franklin Resources’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,319
Closed -$20.7K – 2689
2023
Q3 		$20.7K Sell
2,319
-18
-0.8% -$173 ﹤0.01% 2595
2023
Q2 		$20.2K Sell
2,337
-83
-3% -$885 ﹤0.01% 2667
2023
Q1 		$25.5K Sell
2,420
-128
-5% -$3.87K ﹤0.01% 2235
2022
Q4 		$86.4K Sell
2,548
-967
-28% -$46.8K ﹤0.01% 2148
2022
Q3 		$168K Buy
+3,515
New +$209K ﹤0.01% 2017
2022
Q2 		– Sell
-709
Closed -$57K – 2429
2022
Q1 		$57K Sell
709
-376
-35% -$55.6K ﹤0.01% 2355
2021
Q4 		$220K Buy
1,085
+287
+36% +$62.3K ﹤0.01% 2202
2021
Q3 		$215K Buy
+798
New +$192K ﹤0.01% 2212
2018
Q4 		– Sell
-74,180
Closed -$67.8M – 1509
2018
Q3 		$67.8M Buy
74,180
+10,227
+16% +$8.73M 0.03% 464
2018
Q2 		$46.8M Buy
63,953
+20,260
+46% +$23.4M 0.02% 549
2018
Q1 		$69.6M Buy
+43,693
New +$56.3M 0.04% 445
2014
Q4 		– Sell
-86,975
Closed -$15.7M – 1592
2014
Q3 		$15.7M Sell
86,975
-115,472
-57% -$22.1M 0.01% 940
2014
Q2 		$38.9M Sell
202,447
-480
-0.2% -$84.9K 0.02% 691
2014
Q1 		$36.9M Buy
202,927
+50,698
+33% +$10M 0.02% 686
2013
Q4 		$25.9M Buy
152,229
+24,773
+19% +$4M 0.01% 734
2013
Q3 		$20M Buy
127,456
+44,616
+54% +$8.25M 0.01% 803
2013
Q2 		$14.4M Buy
+82,840
New +$12.7M 0.01% 840

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources's NKTR Position: Q4 2023 in Review

Franklin Resources sold out of Nektar Therapeutics (NKTR) in Q4 2023, closing a stake of 2,319 shares — an estimated $20.7K sold.

Franklin Resources first reported a position in NKTR in Q2 2013 and held it in 17 quarters. The position peaked at $69.6M in Q1 2018. 125 funds tracked by Wall St. Rank hold NKTR as of Q4 2023.

  • Franklin Resources reported no remaining Nektar Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Franklin Resources sold 2,319 Nektar Therapeutics shares in Q4 2023, an estimated $20.7K.
  • Franklin Resources first reported a position in Nektar Therapeutics in Q2 2013 and held it in 17 quarters.
  • Franklin Resources's Nektar Therapeutics position peaked at $69.6M in Q1 2018.
  • 125 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2023.

Based on Franklin Resources's 13F filing for Q4 2023, filed 9 Feb 2024.